Corporate Profile for QED Solutions, dated May 10, 2002.Business Editors --(BUSINESS WIRE) The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.
Published Date: May 10, 2002
Company Name: QED Solutions
Address: 8300 Greensboro Drive
McLean, VA 22102
Main Telephone
Number: 703/821-3200
Internet Home
Page Address
(URL) www.qedrx.com
Chief Executive
Officer: Victor Gogolak
Chief Financial
Officer: Nancy Jenkins
Investor Relations
Contact: Victor Gogolak
Business number: 703/821-3200
E-mail address: vgogolak@qedrx.com
Public Relations
Contact: Renee Lewis
Business number: 703/821-3200 x 223
E-mail address: rlewis@qedrx.com
Industry: pharmaceutical
Company description: QED QED abbr. Latin quod erat demonstrandum (which was to be demonstrated) QED which was to be shown or proved [Latin quod erat demonstrandum] Noun 1. Solutions, Inc. develops analytical analytical, analytic pertaining to or emanating from analysis. analytical control control of confounding by analysis of the results of a trial or test. tools and software for managing risks related to drug safety issues. QED Solutions designs, develops and delivers products that provide state-of-the art solutions in drug safety surveillance practices throughout the entire lifecycle development process of pharmaceuticals, from the various clinical trial stages to the postmarket stage. Its proprietary Qscan(TM) suite of products monitors both company proprietary adverse event data and publicly available data sources. Est.: 1998; privately held. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion